Education
About Us
Working with TipRanks
Follow Us
Novonesis (NVZMY)
OTHER OTC:NVZMY
NVZMY Stock Chart & Stats
$63.44
-$0.61(-1.09%)
At close: 4:00 PM EST
$63.44
-$0.61(-1.09%)
Day’s Range― - ―
52-Week Range$54.26 - $75.69
Previous CloseN/A
Volume8.66K
Average Volume (3M)1.56K
Market Cap
$29.56B
Enterprise Value$36.74B
Total Cash (Recent Filing)$365.40M
Total Debt (Recent Filing)$3.32B
Price to Earnings (P/E)87.8
Beta0.29
Next Earnings
Nov 06, 2025EPS Estimate
0.66Last Dividend Ex-Date
Sep 02, 2025Dividend Yield1.52%
Share Statistics
EPS (TTM)0.42
Shares Outstanding414,555,050
10 Day Avg. Volume2,114
30 Day Avg. Volume1,559
Financial Highlights & Ratios
PEG Ratio-6.48
Price to Book (P/B)2.23
Price to Sales (P/S)48.49
P/FCF Ratio281.59
Enterprise Value/Market Cap1.24
Enterprise Value/Revenue3.84
Enterprise Value/Gross Profit16.84
Enterprise Value/Ebitda39.46
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Novonesis News
NVZMY FAQ
What was Novonesis’s price range in the past 12 months?
Novonesis lowest stock price was $54.26 and its highest was $75.69 in the past 12 months.
What is Novonesis’s market cap?
Novonesis’s market cap is $29.56B.
When is Novonesis’s upcoming earnings report date?
Novonesis’s upcoming earnings report date is Nov 06, 2025 which is in 11 days.
How were Novonesis’s earnings last quarter?
Novonesis released its earnings results on Aug 21, 2025. The company reported $0.418 earnings per share for the quarter, missing the consensus estimate of $0.67 by -$0.252.
Is Novonesis overvalued?
According to Wall Street analysts Novonesis’s price is currently Overvalued.
Does Novonesis pay dividends?
Novonesis pays a Semiannually dividend of $0.35 which represents an annual dividend yield of 1.52%. See more information on Novonesis dividends here
What is Novonesis’s EPS estimate?
Novonesis’s EPS estimate is 0.66.
How many shares outstanding does Novonesis have?
Novonesis has 414,555,050 shares outstanding.
What happened to Novonesis’s price movement after its last earnings report?
Novonesis reported an EPS of $0.418 in its last earnings report, missing expectations of $0.67. Following the earnings report the stock price went down -7.335%.
Which hedge fund is a major shareholder of Novonesis?
Currently, no hedge funds are holding shares in NVZMY
Novonesis Stock Smart Score
Company Description
Novonesis
Novonesis (NVZMY) is a technology-driven company specializing in advanced digital solutions tailored for the healthcare sector. The company focuses on providing innovative software and data analytics services that enhance patient care, streamline healthcare operations, and improve clinical outcomes. Its core products include electronic health record (EHR) systems, telehealth platforms, and predictive analytics tools, which are designed to support healthcare providers in delivering efficient and effective services.
NVZMY Company Deck
NVZMY Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a solid performance in the first half of 2025 with strong organic sales growth and improved EBITDA margins. However, challenges such as currency headwinds and softness in the Beverages segment present some concerns. The company's positive outlook and strategic plans for future growth contribute to a balanced sentiment.View all NVZMY earnings summariesNVZMY Revenue Breakdown
28.53% Household Care
24.83% Bioenergy
22.07% Food, Beverages & Human Health
12.82% Grain & Tech Processing
11.75% Agriculture & Animal Health
Technical Analysis
International Flavors & Fragrances
―
LyondellBasell
―
PPG Industries
―
RPM International
―
DuPont de Nemours
―
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---